XSJ05, a derivative of camptothecin (CPT), exhibits anti-cancer activity by inhibiting topoisomerase I (Topo I). This compound induces DNA double-strand breaks, leading to DNA damage. Furthermore, XSJ05 stifles the growth of colorectal cancer (CRC), halts the cell cycle in the G2/M phase, and induces apoptosis.
Molekulargewicht:
539.6
CAS Nummer:
[1461652-87-8]
Formel:
C29H25N5O4S
Target-Kategorie:
Topoisomerase|||Apoptosis
T200042
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten